Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations43
Assessing patient understanding of pharmacogenomic test results: a qualitative study28
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans28
Genetics and response to treatment with metformin for type 2 diabetes28
Patient comprehension of preemptive pharmacogenomic results27
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting24
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1217
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization13
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review13
Rapid point of care testing: the next frontier in pharmacogenomics12
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing12
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison12
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis12
3.1296780109406